EU Accelerated Assessment Tracker: EMA To Fast Track Thalassemia Gene Therapy, New HIV Drug

Bluebird Bio’s LentiGlobin and Theratechnologies’ Trogarzo are both first of their kind treatments for transfusion-dependent β-thalassemia and HIV respectively.

PS1808_Racetrack_404954305_1200.jpg
Two new drugs could get to market faster in the EU • Source: Shutterstock

More from Review Pathways

More from Pathways & Standards